3,250,000 SHARES TRANSMEDICS GROUP, INC. COMMON STOCK, NO PAR VALUE PER SHARE UNDERWRITING AGREEMENT August 4, 2022Underwriting Agreement • August 8th, 2022 • TransMedics Group, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledAugust 8th, 2022 Company Industry Jurisdiction
5,000,000 SHARES TRANSMEDICS GROUP, INC. COMMON STOCK, NO PAR VALUE PER SHARE UNDERWRITING AGREEMENT May 26, 2020Underwriting Agreement • May 28th, 2020 • TransMedics Group, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledMay 28th, 2020 Company Industry JurisdictionThe undersigned understands that J.P. Morgan Securities LLC (“J.P. Morgan”) and Morgan Stanley & Co. LLC (“Morgan Stanley”) propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with TransMedics Group, Inc., a Massachusetts corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including J.P. Morgan and Morgan Stanley (the “Underwriters”), of shares (the “Shares”) of the common stock, no par value per share, of the Company (the “Common Stock”). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.